GSK1325756

• Catalog number
  B1103-1
• Price
  Please ask
• Size
  1 mg

• Alternative_name
  1-[4-chloro-2-hydroxy-3-[(3S)-piperidin-3-yl]sulfonylphenyl]-3-(3-fluoro-2-methylphenyl)urea; Danirixin
• Description
  GSK1325756 is a selective and reversible CXCR2 antagonist with IC₅₀ value of 12.5 nM. GSK1325756 displays anti-inflammatory effects in various preclinical and clinical models.
• CAS Number
  954126-98-8
• Structure Available
  Yes
• Salt Form
  No
• Molecular Formula
  C₁₉H₂₁ClFN₃O₄S
• Molecular Weight
  441.9
• Cell Permeable
  Yes
• Purity
  ≥98% by HPLC
• Solubilities
  DMSO (> 8 mg/ml)
• Handling
  Protect from air and light
• Tag Line
  GSK1325756 is selective and reversible CXCR2 antogonist
• Storage Condition
  -20°C
• Shipping Condition
  gel pack
• Shelf Life
  36 months
• PubChem CID
  24780598
• PubChem CID Link
• SMILES
  CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)C3CCCNC3)O
• InChi
  InChI=1S/C19H21ClFN3O4S/c1-11-14(21)5-2-6-15(11)23-19(26)24-16-8-7-13(20)18(17(16)25)29(27,28)12-4-3-9-22-10-12/h2,5-8,12,22,25H,3-4,9-10H2,1H3,(H2,23,24,26)/t12-/m0/s1
• InChi Key
  NGYNBSHYFOFVLS-LBPRGKRZSA-N
• Data Sheet Link
• MSDS Available
  Yes

• Gene target
  GSK1325756  
• Short name
  GSK1325756
• Alternative name
  GSK1325756

Product images

Similar products